Yep, but there is a big hint in this announcement on what could be expected in near future and when the trial is completed. Good to be caution but big money might try to take small parcel as pilot buy & supply being limited at this price, it could bring provide good appreciation to SP.
If trial successful as management hinting out, this could re-rate back hard due to current interest in bio sector.
fingers crossed![]()
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C-2 Study Update
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-8
-
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online